Education
About Us
Working with TipRanks
Follow Us
IO Biotech (IOBT)
NASDAQ:IOBT
Total Valuation
IO Biotech has a market cap or net worth of $128.47M. The enterprise value is $71.80M.
Market Cap$128.47M
Enterprise Value$71.80M
Share Statistics
IO Biotech has 65,880,910 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding65,880,910
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
IO Biotech’s return on equity (ROE) is -2.03 and return on invested capital (ROIC) is -194.65%.
Return on Equity (ROE)-2.03
Return on Assets (ROA)-1.41
Return on Invested Capital (ROIC)-194.65%
Return on Capital Employed (ROCE)-1.97
Revenue Per Employee0.00
Profits Per Employee-1.19M
Employee Count80
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of IO Biotech is ―. IO Biotech’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value1.29
Price to FCF―
Price to Operating Cash Flow-1.68
PEG Ratio―
Income Statement
In the last 12 months, IO Biotech had revenue of 0.00 and earned -95.49M in profits. Earnings per share was -1.45.
Revenue0.00
Gross Profit-849.00K
Operating Income-95.18M
Pretax Income-94.05M
Net Income-95.49M
EBITDA-93.20M
Earnings Per Share (EPS)-1.45
Cash Flow
In the last 12 months, operating cash flow was -83.33M and capital expenditures -75.00K, giving a free cash flow of -83.40M billion.
Operating Cash Flow-83.33M
Free Cash Flow-83.40M
Free Cash Flow per Share-1.27
Dividends & Yields
IO Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.22
52-Week Price Change100.00%
50-Day Moving Average1.77
200-Day Moving Average1.19
Relative Strength Index (RSI)51.21
Average Volume (3m)6.15M
Important Dates
IO Biotech upcoming earnings date is Nov 5, 2025, After Close (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend Date―
Financial Position
IO Biotech as a current ratio of 3.33, with Debt / Equity ratio of 6.67%
Current Ratio3.33
Quick Ratio3.33
Debt to Market Cap0.01
Net Debt to EBITDA0.62
Interest Coverage Ratio0.00
Taxes
In the past 12 months, IO Biotech has paid 1.44M in taxes.
Income Tax1.44M
Effective Tax Rate-0.02
Enterprise Valuation
IO Biotech EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.03.
EV to Sales0.00
EV to EBITDA-0.03
EV to Free Cash Flow-0.03
EV to Operating Cash Flow-0.03
Balance Sheet
IO Biotech has $28.13M in cash and marketable securities with $8.36M in debt, giving a net cash position of -$19.77M billion.
Cash & Marketable Securities$28.13M
Total Debt$8.36M
Net Cash-$19.77M
Net Cash Per Share-$0.30
Tangible Book Value Per Share$0.71
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for IO Biotech is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside361.54% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast-9.69%